The relationship between male testosterone hormone and some female hormones in women with polycystic ovary syndrome (PCOS)
الباحث الأول:
Dalal Abdul Hussain Kadium
الباحثين الآخرين:
Ghsoon Ghanem Kaem, b Zaineb Zaineb Assim Al Safar Al Saeq and
المجلة:
Contemp Med Sci
تاريخ النشر:
None
مختصر البحث:
female hormones in patients with polycystic ovary syndrome (PCOS) and find the relationship between the male testosterone hormone
and female hormones in patients with PCOS and to know the reasons for these changes in view of the prevalence of PCOS …
female hormones in patients with polycystic ovary syndrome (PCOS) and find the relationship between the male testosterone hormone
and female hormones in patients with PCOS and to know the reasons for these changes in view of the prevalence of PCOS and its
importance as a major problem affecting the health of women and her fertility.
Methods The hormones included LH, FSH, PRL, estradiol (E2), progesterone (P4) and LH/FSH ratio in patients with PCOS compared with
control group, and to find the relationship between male testosterone hormone and female hormones under the study in patients with
PCOS. Fifty-five female patients with PCOS in reproductive age with body mass index (BMI) (25.01 ± 1.70 kg/m2), aged 15–46 years old and
who recalculated fertility centre of teaching Al-Sadr hospital in Al-Najaf Al-Ashraf Governorate from 1/9/2013 to 1/10/2014, compared with
20 non-patients women with PCOS with BMI (23.87 ± 2.66 kg/m2) and age 17–47 years old as control group.
Results The results showed that there was a significant increasing (p < 0.05) in insulin, testosterone, LH, PRL and LH/FSH ratio in patients
with PCOS compared with control group, while there was a significant decreasing (p < 0.05) in FSH, E2 and P4 in patients with PCOS
compared with non-patients women.
Conclusion As the results have shown that there was a positive significant relationship between testosterone and LH, PRL and LH/FSH ratio
while the relationship was negative significant between testosterone and FSH, E2 and P4 in patients with PCOS.
